Evolent Health (EVH) Misses Q1 EPS by 1c, Offers Guidance

Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $247.3 million versus the consensus estimate of $239.1 million.

GUIDANCE:

Evolent Health sees Q2 2020 revenue of $236-247 million, versus the consensus of $240.3 million.

Evolent Health sees FY2020 revenue of $935-985 million, versus the consensus of $963.8 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
• KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty